Executive with 6+ years experience in C-suite and broad executive leadership experience including corporate development/strategy, IPO/fundraising, external communication (Wall Street/investors/analysts, regulatory agencies, KOLs/investigators, and general public), and team creation/management. Clinical development experience includes: virology (RSV, Hepatitis B/C/D, influenza), hepatology (NASH), cardiology, pulmonology, and rare diseases. Expertise extends across all phases of development from transitioning compounds into man (FIH) to designing and conducting pivotal ph3 registration studies.